The Scientific Research team at Rgenta Therapeutics focuses on discovering and developing small-molecule medicines targeting RNA to treat oncology and neurological disorders. Comprising scientists, senior scientists, research associates, and scientific advisors, the team employs cutting-edge research methodologies to identify and validate novel therapeutic targets, optimize lead compounds, and advance promising candidates through preclinical development.
View all